On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer ...
TNF inhibitors for the treatment of axial spondyloarthritis may decrease the risk for hip or spine fracture by as much as 29% ...
If you choose medication therapy for post-traumatic stress disorder (PTSD), experts generally recommend selective serotonin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results